Stock Events

Stock Events

Vera Therapeutics 

$42.84
55
-$0.29-0.67% 19:31 Today

Statistics

Day High
43.18
Day Low
41.72
52W High
56.05
52W Low
19.07
Volume
203,875,211
Avg. Volume
-
Mkt Cap
3.08B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.69
-1.34
-0.99
-0.64
Expected EPS
-1.575599
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-299.62MNet Income

Analyst Ratings

83.50Average Price Target
The highest estimate is 125.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
17%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VERA. It's not an investment recommendation.
NVIDIA
14
NVDA
Amazon
13
AMZN
Microsoft
12
MSFT
Palantir Technologies
12
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that competes in the development of treatments for various diseases, including those in Vera Therapeutics' focus areas.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie operates in similar therapeutic areas as Vera Therapeutics, including immunology and chronic diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap196.12B
Amgen focuses on human therapeutics, including treatments for serious illnesses, overlapping with Vera Therapeutics' research and development efforts.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that address serious diseases, competing with Vera Therapeutics.
Pfizer
PFE
Mkt Cap137.76B
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including areas where Vera Therapeutics is active.
Novartis
NVS
Mkt Cap293.94B
Novartis focuses on patented medicines, generics, and biosimilars, with a broad portfolio that competes with Vera Therapeutics' offerings.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical segment, competes across various therapeutic areas, including those targeted by Vera Therapeutics.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, aligning as a competitor to Vera Therapeutics.
Vertex Pharmaceuticals
VRTX
Mkt Cap123.19B
Vertex Pharmaceuticals is known for creating transformative medicines for people with serious diseases, directly competing with Vera Therapeutics' mission.
Biogen
BIIB
Mkt Cap29.4B
Biogen focuses on developing therapies for neurological and neurodegenerative diseases, competing in the broader biopharmaceutical space with Vera Therapeutics.

About

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera Therapeutics, Inc. in April 2020.
Show more...
CEO
Dr. Marshall W. Fordyce M.D.
Employees
249
Country
United States
ISIN
US92337R1014

Listings

BOATS
BOATS
VERA.BOATS
XNAS
US
VERA

0 Comments

Share your thoughts

FAQ

What is Vera Therapeutics stock price today?▼
The current price of VERA is $42.84 USD — it has decreased by -0.67% in the past 24 hours. Watch Vera Therapeutics stock price performance more closely on the chart.
What is Vera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Vera Therapeutics stocks are traded under the ticker VERA.
Is Vera Therapeutics stock price growing?▼
VERA stock has risen by +1.3% compared to the previous week, the month change is a +25.53% rise, over the last year Vera Therapeutics has showed a +85.26% increase.
What is Vera Therapeutics market cap?▼
Today Vera Therapeutics has the market capitalization of 3.08B
When is the next Vera Therapeutics earnings date?▼
Vera Therapeutics is going to release the next earnings report on August 06, 2026.
What were Vera Therapeutics earnings last quarter?▼
VERA earnings for the last quarter are -1.69 USD per share, whereas the estimation was -1.33 USD resulting in a -27.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vera Therapeutics revenue for the last year?▼
Vera Therapeutics revenue for the last year amounts to 0 USD.
What is Vera Therapeutics net income for the last year?▼
VERA net income for the last year is -299.62M USD.
How many employees does Vera Therapeutics have?▼
As of July 15, 2026, the company has 249 employees.
In which sector is Vera Therapeutics located?▼
Vera Therapeutics operates in the Health & Wellness sector.
When did Vera Therapeutics complete a stock split?▼
Vera Therapeutics has not had any recent stock splits.
Where is Vera Therapeutics headquartered?▼
Vera Therapeutics is headquartered in Brisbane, United States.